NCT06017362 is a Phase 4 clinical trial of Insulin in Dry Eye, sponsored by Barbara Burgos Blasco.

Who is sponsoring NCT06017362?

NCT06017362 is sponsored by Barbara Burgos Blasco.

What drugs are being tested in NCT06017362?

Interventions in NCT06017362: Insulin, Artificial tear.

What condition does NCT06017362 study?

NCT06017362 studies Dry Eye, Glaucoma.

Is NCT06017362 still recruiting?

NCT06017362 is currently recruiting now. Last updated 22 October 2024.

Last reviewed 2024-10-22 · How we verify

NCT06017362

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

Recruiting now Phase 4 Last updated 22 October 2024

What this trial tests

Phase 4 trial testing Insulin in Dry Eye in 100 participants. Currently enrolling.

Timeline

8 February 2023

Primary endpoint
8 February 2026

8 February 2026

Quick facts

Lead sponsor	Barbara Burgos Blasco
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	8 February 2023
Primary completion	8 February 2026
Estimated completion	8 February 2026
Sites	1 location across Spain

Drugs / interventions tested

Insulin (insulin) — full drug profile →
Artificial tear — full drug profile →

Conditions studied

Dry Eye — all drugs for Dry Eye →
Glaucoma — all drugs for Glaucoma →

Sponsor

Barbara Burgos Blasco

Who can join

18 and older, any sex, with Dry Eye or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors, compared to placebo (artificial tears). The main question aims to answer whether glaucoma patients treated with topical hypotensors could benefit from the use of insulin eye drops for the treatment of dry eye. Participants will be assigned to one of the two treatment arms and will be required to attend four follow-up visits (baseline, 1, 3, and 6 months).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease.
Valdés-Arias D, Locatelli EVT, Sepulveda-Beltran PA, Mangwani-Mordani S, et al · · 2024 · cited 16× · PMID 38652355 · DOI 10.1007/s40265-024-02031-6

Verify or expand the search:

Other trials of Insulin

Trials testing the same drug.

NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07259564 — A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) · Phase 2 · not yet recruiting
NCT06762314 — Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes · Phase 2 · recruiting
NCT06781775 — GDM: Insulin with or Without Metformin? · Phase 4 · recruiting
NCT06391853 — Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study · NA · withdrawn

Other recruiting trials for Dry Eye

Currently open trials in the same condition.

NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting

Other Barbara Burgos Blasco trials

Trials by the same sponsor.

NCT05692739 — Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06017362 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Barbara Burgos Blasco
Last refreshed: 22 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06017362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing